BioXcel Therapeutics Inc (NASDAQ:BTAI)
| 12.11 Delayed Data As of Jun 24 |  +0.05 / +0.41%Today’s Change | 8.80 Today|||52-Week Range 36.49 | -40.43% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -636.0K | -2.1M | -4.5M | -19.3M | |
| Depreciation | -- | 0.00 | 1.0K | 17.0K | ||
| Total Other Cash Flow | 182.0K | 671.0K | 1.6M | 3.1M | ||
| Funds From Operations | -454.0K | -1.4M | -2.9M | -16.2M | ||
| Funds From/For Other Operating Expenses | -174.0K | -155.0K | -736.0K | -2.7M | ||
| Net Cash Flow - Operating Activities | -280.0K | -1.3M | -2.2M | -13.5M | ||
| Investing | Capital Expenditures | -1.0K | -4.0K | 0.00 | -340.0K | |
| Net Cash Flow Investing | -1.0K | -4.0K | 0.00 | -340.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 371.0K | -371.0K | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 281.0K | 1.3M | 2.3M | 56.5M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 507.0K | -- | ||
| Other Uses - Financing | 0.00 | 0.00 | 70.0K | 622.0K | ||
| Net Cash Flow - Financing | 281.0K | 1.3M | 3.1M | 55.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 0.00 | 0.00 | 887.0K | 41.7M | ||
